What reactions will occur after discontinuing ritexitinib? Discontinuation Risks and Precautions
Ritlecitinib as an oralJAK inhibitor, has a significant effect in the treatment of moderate to severe alopecia areata, but the reactions and risks after discontinuation also require the attention of patients and doctors. After stopping the drug, patients may face varying degrees of immune system reactions, which are closely related to the drug's mechanism of action. After stopping the drug, the most common reaction is the recurrence of alopecia areata symptoms, which also means that the effect of the treatment may gradually weaken and hair loss may worsen again.
First, the mechanism of action of ritexitinib is to reduce hair follicle damage by regulating the immune system. When patients stop using ritexitinib, the abnormal response of the immune system may gradually recover, causing T cells to re-attack hair follicles, thereby aggravating hair loss. Therefore, patients may see hair fall out again in the months after stopping the drug, and may even experience more hair loss than before the drug was stopped. For some patients, hair recovery may take longer, or even long-term hair loss may occur after discontinuation of treatment.
In addition, side effects and risks after discontinuing the drug need to be considered. Since ritexitinib itself has a certain inhibitory effect on the immune system, discontinuation of the drug may lead to instability of the immune response and may make patients more vulnerable in terms of immune function. Patients may be at increased risk for infection, especially those who are immunocompromised. Therefore, during the withdrawal process, patients need to be strictly monitored and communicate with their doctors in a timely manner to ensure that the immune system does not overreact.
The timing and method of drug discontinuation also need to be determined based on the patient's specific situation. If a patient is already taking rituxitinib and has achieved a significant therapeutic effect, discontinuation may require a gradual dose reduction rather than an abrupt discontinuation. This helps the immune system adapt to the changes, reducing immune attack on hair follicles and potentially slowing the recurrence of hair loss.
Reference materials:https://www.litfulo.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)